Roham Zamanian

Professor of Medicine ; Director Adult Pulmonary Hypertension Program ; Associate Director Vera Moulton Wall Center; clinical trialist ; photographer.

[Roham Zamanian @docroham]

Excited to have been part of a superb Phase 2 study of Seralutinib in PAH. Read it below:

https://t.co/VYmLwaGIuC

[Roham Zamanian @docroham]

@bmprii Congratulations to you and the team! Excited for our field and our patients. I hope you use your position to “fact-check” misleading news articles suggesting that sotatercept is a reversal agent. You would agree that it hasn’t been tested although we all have opinions it may

[Roham Zamanian @docroham]

Incredible. Hats off to all scientists/investigators/patients(!). Excited to have access to therapy w such a potential. BUT!!!! Inaccurate& misleading news will NOT help our field or patients. Opinion is not fact! @PVRI @Viniciodjperez @AlbertaPHdoc
https://t.co/bZ8ypxtcCF

[Roham Zamanian @docroham]

A pleasure to help pave to define disease modification in PAH. An honor to work with a superb group of colleagues - Exciting think-tank style collab, along with the ever-so-important patient perspective

https://t.co/2iYxrB1Cn0

@PHatStanford @AlbertaPHdoc @PVRI

[Vinicio de Jesus Perez, MD FAHA FCCP ATSF @Viniciodjperez]

Are we ready for “disease modification”? We got the scoop! Check out the paper-available today online.

[Roham Zamanian @docroham]

@AlbertaPHdoc @ATSBlueEditor @Viniciodjperez @VApccm @BogaardHarm @mpsotka @PHACanada @PHAssociation @PVRI @UAlberta_DoM What a great experience working with this team!

[Vinicio de Jesus Perez, MD FAHA FCCP ATSF @Viniciodjperez]

Are we ready for “disease modification”? We got the scoop! Check out the paper-available today online.

[Roham Zamanian @docroham]

Difficult news to hear….a huge loss for the field and our community. On behalf of @PHatStanford, our deepest condolences to the Newman family and Vanderbilt colleagues. His legacy will live on thru his contributions to our field and the many he has mentored.

[The Pulmonary Vascular Research Institute @PVRI]

The PVRI is deeply saddened by the loss of Dr John Newman, a cherished member of the Pulmonary Vascular Disease community. His dedication and expertise have left an indelible mark on our field. Sending heartfelt condolences to his loved ones and colleagues during this time.

[Roham Zamanian @docroham]

@rajmathai @nbcbayarea @janellewang @AudreyAsistioTV Congratulations @rajmathai !!! How time flies.

[Roham Zamanian @docroham]

@julielw28 @VibeePresents @U2 @SphereVegas did you receive a reply?

[Roham Zamanian @docroham]

@VibeePresents @U2 @SphereVegas I literally have DM'ed @VibeePresents here and FB and emailed no reply. Can you please respond.

[Roham Zamanian @docroham]

@Viniciodjperez Bravo

[Roham Zamanian @docroham]

RIP Major Brian Shul! Incredible story of an aviator. - resilience, courage, and grit. Spoke at our @PHatStanford pulmonary hypertension symposium a few years ago….

https://t.co/0Dm2JQ8t8u

[Roham Zamanian @docroham]

Social hour at ATS with Stanford PH team & friends @StanfordPACCM @PHatStanford

[Roham Zamanian @docroham]

Dr Andrew Sweatt - The Jane Moris Award recipient @ATS_PC Congratulations Andy!!!!!! Made us proud. @StanfordPACCM @PHatStanford

[Roham Zamanian @docroham]

Congratulations to Andy Sweatt & Adam Andruska for amazing presentations on vasoreactivity in PAH & PVOD risk score. Did us proud!! @ATS_PC @atscommunity @StanfordPACCM

[Roham Zamanian @docroham]

@StanfordPACCM @atscommunity @andreajonasmd Who’s that guy photo-bombing in the front 😭😱

[Roham Zamanian @docroham]

@NASA at ATS! Pulmonary vascular function in space …. Now that’s something I can get hyped about! @ATS_PC

[Roham Zamanian @docroham]

@TamCardio @TamCardio was our honor to have you participate! After all we are neighbors (just across the small pond) 😭. Cheers to more collaborations and good discussions.

[Yuichi Tamura/ 田村雄一：心臓/循環器の学際領域のひと @TamCardio]

@docroham Thanks for the invitation and wonderful discussions. #DIPH #Stanford